We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Randomized Study of Letrozole and Trilostane for Medical Abortion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01615211
Recruitment Status : Terminated (No access to study drug Trilostan. Company closed down)
First Posted : June 8, 2012
Last Update Posted : May 18, 2015
Karolinska Institutet
The University of Hong Kong
Information provided by (Responsible Party):
Kristina Gemzell Danielsson, Karolinska Institutet

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : October 2013
  Study Completion Date : October 2013